Q32 Bio Inc. (QTTB) — 10-Q Filings
All 10-Q filings from Q32 Bio Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
- 10-Q Filing — May 5, 2026
-
Q32 Bio's Net Loss Widens to $70.1M Amid R&D Push
— Aug 6, 2025 Risk: high
Q32 Bio Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company's net loss for the thre -
Q32 Bio Inc. Files Q1 2025 10-Q
— May 8, 2025 Risk: medium
Q32 Bio Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Homology Medicines, Inc., reported on its financial status and -
Q32 Bio Files Q3 2024 10-Q
— Nov 7, 2024 Risk: medium
Q32 Bio Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Homology Medicines, Inc., is incorporated in Delaware and h -
Q32 Bio Inc. Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
Q32 Bio Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Homology Medicines, Inc., reported on its financial status and b -
Q32 Bio Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
Q32 Bio Inc. (QTTB) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Q32 Bio Inc. filed a 10-Q for the period ending March 31, 2024. The company was
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX